To tackle the opioid crisis, the Trump administration should push for the Alternatives to PAIN Act in Congress, which would ...

A University of Rochester study revealed that over-the-counter drugs, like acetaminophen and ibuprofen, are more effective ...

In Idaho, more than one out of every six people is older than 65. These seniors hold invaluable wisdom and form the backbone ...

A study concluded that the use of over-the-counter pain relievers is more effective than opioids for pain management after ...

It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...

A new landmark study involving the University of Rochester could change how dentists treat pain after wisdom tooth ...

Seniors are at higher risk for opioid problems for a simple reason – they are more likely to need outpatient surgeries.

Unafra, with the active ingredient opiranserin hydrochloride, is an injectable medication developed for managing ...

The FDA is set to consider approval of an alternative to opioids developed by Vertex Pharmaceuticals, The Washington Post reported Jan. 13.

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

The FDA is expected to grant approval to a new pain medication with big potential—mainly because it's a non-opioid and is ...

More patients treated with ZTlido® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% vs. 45.5%).Of all study patients reporting a decrease in ...